MALIGNANCIES
Clinical trials for MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MALIGNANCIES trials appear
Sign up with your email to follow new studies for MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy aims to fight hard-to-treat blood cancers
Disease control Not yet recruitingThis early-stage study tests a new treatment called IASO207 for people with B-cell blood cancers that have come back or not responded to other treatments. The main goals are to check safety and find the right dose. About 18 adults aged 18 to 75 will take part. The treatment uses …
Matched conditions: MALIGNANCIES
Phase: EARLY_PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 26, 2026 11:33 UTC
-
New injection JL19001 enters early human testing for tough cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called JL19001 in people with advanced solid tumors or a type of blood cancer (B-cell non-Hodgkin lymphoma) that has come back or not responded to standard treatments. The main goal is to find a safe dose and check for side effects. About 1…
Matched conditions: MALIGNANCIES
Phase: PHASE1 • Sponsor: Jecho Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:26 UTC